MedTrace Logo

Vitamin D and Vascular Health in Children

NCT01797302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2020-06-24

Study results available
· View outcomes & findings →

Summary

In this study, we will test the central hypothesis that enhancement of vitamin D status in obese and overweight children will improve their vascular health and their cardiovascular disease (CVD) and metabolic syndrome risk profile.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Tablet form

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Office of Dietary Supplements (ODS)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Kumaravel Rajakumar, MD, MS · University of Pittsburgh, Children's Hospital of Pittsburgh of UPMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2018-08-13
Completion
2018-08-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01797302 on ClinicalTrials.gov